Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Carmen Peral,1 Francisco Sánchez-Ballester,2 José M García-Mediero,3 Jaime Ramos,1 Javier Rejas1 1Health Economics & Outcomes Research Department, Pfizer, Alcobendas (Madrid), 2Department of Urology, Hospital General Universitario de Valencia, Valencia, 3Depa...

Full description

Bibliographic Details
Main Authors: Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Antimuscarinic
Fesoterodine
Flexible-dose
Overactive bladder
Online Access:https://www.dovepress.com/cost-effectiveness-analysis-of-fesoterodine-flexible-dose-in-newly-dia-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/cost-effectiveness-analysis-of-fesoterodine-flexible-dose-in-newly-dia-peer-reviewed-article-CEOR

Similar Items